Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket

Gainers

• Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of $46.5 million.
• Blue Star Foods Corp. (NASDAQ:BSFC) climbed 29.9% to $0.2061 in pre-market trading after jumping around 22% on Monday.
• Pear Therapeutics, Inc.. (NASDAQ:PEAR) gained 24.1% to $0.26 in pre-market trading after dropping 46% on Monday. Pear Therapeutics, last week, said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction.
• First Republic Bank (NYSE:FRC) rose 20.6% to $14.69 in pre-market after dropping 47% on Monday. Jamie Dimon, CEO at JPMorgan Chase & Co. (NYSE:JPM), is leading talks with other leaders of prominent banks to resolve the First Republic crisis, the Wall Street Journal reported on Monday.
• Bird Global, Inc. (NYSE:BRDS) gained 17.6% to $0.13 in pre-market trading after declining 8% on Monday. Bird Global recently reported better-than-expected Q4 sales results.
• Catalyst Biosciences, Inc. (NASDAQ:CBIO) gained 16.6% to $0.22 in pre-market trading. GC Biopharma recently signed an Asset Purchase Agreement with the company.
• Aurora Innovation, Inc. (NASDAQ:AUR) shares rose 15.7% to $1.33 in pre-market trading after dropping around 9% on Monday.
• Selecta Biosciences, Inc. (NASDAQ:SELB) shares rose 14.1% to $1.46 in pre-market trading. Selecta Biosciences said Phase 3 DISSOLVE program of SEL-212 in chronic refractory gout met primary endpoint.
• Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares rose 13.4% to $0.1150 in pre-market trading.
• Edible Garden AG Incorporated (NASDAQ:EDBL) rose 11.2% to $4.11 in pre-market trading after gaining 14% on Monday. Edible Garden is scheduled to host a conference call on March 22, 2023 to discuss financial results for the quarter ended Dec. 31, 2022.

Losers

• Qutoutiao Inc. (NASDAQ:QTT) fell 64.2% to $0.25 in pre-market after gaining 3% on Monday.
• PainReform Ltd. (NASDAQ:PRFX) fell 23.8% to $0.4213 in pre-market trading. PainReform announced commencement of Phase 3 clinical trial to evaluate PRF-110 in patients undergoing bunionectomy surgery.
• First Majestic Silver Corp. (NYSE:AG) fell 17.1% to $6.17 in pre-market trading. First Majestic Silver temporarily suspended mining activities and reduced its workforce at Jerritt Canyon, which represented 21% of the company's 2022 revenue.
• Iveda Solutions, Inc. (NASDAQ:IVDA) shares dropped 12.8% to $0.95 in pre-market trading after gaining over 5% on Monday.
• Boxed, Inc. (NYSE:BOXD) fell 12.3% to $0.1202 in pre-market trading after jumping over 35% on Monday.
• Connect Biopharma Holdings Limited (NASDAQ:CNTB) fell 12.1% to $1.16 in pre-market trading after gaining 20% on Monday. Connect Biopharma announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).
• ThermoGenesis Holdings, Inc. (NASDAQ:THMO) fell 11.7% to $3.93 in pre-market trading. ThermoGenesis closed $3 million private placement priced at-the-market under NASDAQ rules.
• Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares fell 11.2% to $0.1278 in pre-market trading. Allarity Therapeutics shares jumped 37% on Monday after the company said it dosed the first patient in its trial studying advanced solid tumors.
• Lichen China Limited (NASDAQ:LICN) fell 11.1% to $1.90 in pre-market trading.
• Gelesis Holdings, Inc. (NASDAQ:GLS) shares fell 9.5% to $0.1900 in pre-market trading after jumping over 90% on Monday.

Now Read This: Fear & Greed Index Remains In 'Fear' Zone; US Stocks Settle Higher